Thiemann disease, familial form

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3314OMIM:165700M93.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thiemann disease (also known as Thiemann epiphyseal disease or familial avascular necrosis of the phalangeal epiphyses) is a rare inherited skeletal disorder characterized by avascular necrosis (loss of blood supply leading to bone death) of the epiphyses (growth plates) of the phalangeal bones of the hands and, less commonly, the feet. The condition primarily affects the proximal interphalangeal joints of the fingers, leading to progressive joint swelling, stiffness, pain, and eventual deformity. Onset typically occurs during childhood or adolescence, often becoming apparent during periods of active growth. The fingers may develop a characteristic fusiform (spindle-shaped) swelling, and radiographic imaging reveals irregularity, fragmentation, and flattening of the affected epiphyses. The familial form of Thiemann disease follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene from one affected parent is sufficient to cause the condition. Some cases have been linked to mutations in genes involved in cartilage and bone development, though the precise genetic basis is not fully established in all families. The disease predominantly affects the musculoskeletal system, and the degree of functional impairment can vary considerably among affected individuals, ranging from mild joint stiffness to significant limitation of hand function. There is currently no specific cure or disease-modifying treatment for Thiemann disease. Management is primarily supportive and symptomatic, focusing on pain relief through analgesics and anti-inflammatory medications, physical therapy to maintain joint mobility, and occupational therapy to preserve hand function. In severe cases with significant joint deformity or functional impairment, surgical intervention may be considered. The prognosis is generally favorable, as the disease tends to stabilize after skeletal maturity is reached, though residual joint deformity and some degree of functional limitation may persist.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Thiemann disease, familial form.

View clinical trials →

No actively recruiting trials found for Thiemann disease, familial form at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Thiemann disease, familial form community →

No specialists are currently listed for Thiemann disease, familial form.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Thiemann disease, familial form.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Thiemann disease, familial formForum →

No community posts yet. Be the first to share your experience with Thiemann disease, familial form.

Start the conversation →

Latest news about Thiemann disease, familial form

No recent news articles for Thiemann disease, familial form.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Thiemann disease, familial form

What is Thiemann disease, familial form?

Thiemann disease (also known as Thiemann epiphyseal disease or familial avascular necrosis of the phalangeal epiphyses) is a rare inherited skeletal disorder characterized by avascular necrosis (loss of blood supply leading to bone death) of the epiphyses (growth plates) of the phalangeal bones of the hands and, less commonly, the feet. The condition primarily affects the proximal interphalangeal joints of the fingers, leading to progressive joint swelling, stiffness, pain, and eventual deformity. Onset typically occurs during childhood or adolescence, often becoming apparent during periods of

How is Thiemann disease, familial form inherited?

Thiemann disease, familial form follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Thiemann disease, familial form typically begin?

Typical onset of Thiemann disease, familial form is juvenile. Age of onset can vary across affected individuals.